---
layout: minimal-medicine
nav_exclude: true
title: Amrinone
---

# Amrinone

**Generic Name:** Amrinone

**Usage:** Amrinone is a positive inotropic agent used to treat severe congestive heart failure (CHF) when other treatments have not been effective. It is typically used in short-term situations, such as when a patient is awaiting a heart transplant or during a period of acute decompensation.  It's important to note that it is not a first-line treatment for CHF.

**Side Effects:** Amrinone can cause a range of side effects, some common and some serious.

* **Common:**  Headache, nausea, vomiting, diarrhea, abdominal pain, dizziness, hypotension (low blood pressure), arrhythmias (irregular heartbeat), thrombocytopenia (low platelet count).
* **Serious:** Ventricular arrhythmias (including potentially fatal ventricular fibrillation), hepatic (liver) dysfunction, including hepatitis, and rarely, agranulocytosis (severe reduction in white blood cells).  These serious side effects necessitate close monitoring of the patient's blood counts and liver function.

**How it Works:** Amrinone is a phosphodiesterase inhibitor.  It works by increasing the amount of calcium available within heart muscle cells.  This increased calcium availability enhances the force of contraction (inotropy) and increases the heart's output, helping the heart pump more blood more effectively. It also has some vasodilating effects, which means it can help relax blood vessels, reducing the workload on the heart.

**FAQs:**

* **Q: Is amrinone a first-line treatment for heart failure?** A: No.  It's typically reserved for severe cases of heart failure refractory to other treatments like ACE inhibitors, beta-blockers, and diuretics.
* **Q: How is amrinone administered?** A:  Amrinone is administered intravenously (IV).
* **Q: How often is blood work monitored during amrinone treatment?** A:  Regular blood tests, including complete blood counts (CBC) and liver function tests (LFTs), are crucial to monitor for potentially serious side effects like thrombocytopenia and hepatotoxicity.  The frequency of monitoring will be determined by the physician based on the patient's condition.
* **Q: Are there any drug interactions with amrinone?** A: Yes, potential interactions exist with several medications.  It's vital to inform the physician of all medications, supplements, and herbal remedies being taken.  This is especially important for drugs affecting the heart or liver.
* **Q:  What are the signs of a serious side effect that I should report immediately?** A:  Immediately report any signs of serious side effects such as chest pain, severe shortness of breath, rapid or irregular heartbeat, jaundice (yellowing of the skin or eyes), unusual bleeding or bruising, or any significant changes in your overall condition.


**Disclaimer:** This information is for educational purposes only and should not be considered medical advice.  Always consult with a healthcare professional for diagnosis and treatment of any medical condition.  The information provided here does not cover all possible side effects or drug interactions.


**Note:** This information is AI-generated or crowd-sourced and may not be accurate. Please consult a medical professional for verified advice.